Borderline Personality and Substance Use in Columbus, GA

Research on borderline personality and substance use varies by setting; learn what this overlap may mean and why estimates need careful context in Georgia.

Two adults seated facing each other in a bright room.

Borderline personality disorder and substance use disorders can occur in the same person, but overlap is not a diagnosis. Research estimates depend on who was studied, which conditions were counted, and whether researchers measured current or lifetime diagnoses. For adults and loved ones in Columbus, GA, the useful takeaway is not a single percentage. It is understanding what the evidence can tell a care team and what it cannot establish about an individual.

This distinction protects against two mistakes: assuming substance use explains every emotional difficulty, or assuming impulsive behavior automatically means borderline personality disorder. Both concerns deserve careful description rather than a label based on one behavior.

What does borderline personality disorder mean?

Borderline personality disorder, or BPD, involves difficulties with emotions, sense of self, relationships, and everyday functioning. Recognizing those concerns is different from deciding which services belong in an individualized addiction treatment plan. Adults using River City Recovery’s contact options can discuss general outpatient care without already knowing a diagnosis or choosing a program.

The National Institute of Mental Health’s BPD information, revised in 2025 and accessed November 6, 2026, describes BPD as a serious mental illness affecting how people feel about themselves and others. Difficulty regulating emotions can involve impulsivity, an unstable or changing sense of self, and troubled relationships. Its description is general condition education, not a finding that these experiences identify BPD in everyone who reports them.

NIMH emphasizes that people do not all experience the same symptoms. Severity, frequency, and duration vary. Some possible experiences include:

  • Intense, changing moods and difficulty controlling anger.
  • A changing or distorted self-image and chronic feelings of emptiness.
  • Fear of real or perceived abandonment and intense, unstable relationships.
  • Impulsive or reckless behavior, which may include substance use but can also involve other activities.

These examples are not a self-diagnostic checklist. NIMH explains that a licensed mental health professional diagnoses BPD through a thorough discussion of symptoms and personal and family history, including mental illness history. A medical examination can help rule out other possible causes. A relative’s observations may describe a concern, but they do not replace that assessment.

Variability also matters when comparing two people with the same diagnosis. One person’s most disruptive concern may involve relationships, while another describes a different pattern of emotional or behavioral difficulties. A diagnosis does not establish that their experiences, support needs, or clinical plans must be identical.

How often do BPD and substance use disorders occur together?

Research finds frequent co-occurrence, but the percentage depends on which diagnosis defines the starting group and where people were recruited. That distinction matters when considering care organized around individual needs or asking admissions about assessment: a group finding cannot establish either diagnosis for one adult.

A 2018 review by Trull and colleagues, accessed November 6, 2026, examined 70 studies published from 2000 through 2017. The adult samples came from multiple countries and included inpatient, residential, outpatient, forensic, community, and mixed settings. These are international research findings, not estimates specifically for the United States, Georgia, or River City Recovery participants.

Among studies reporting current diagnoses, the review combined 10,086 adults with a current substance use disorder, or SUD, or receiving addiction treatment. Of those participants, 22.1% also had a current BPD diagnosis. The table shows how the starting population and treatment setting remained attached to the estimates.

Mixed-country adult samples in studies published 2000–2017, summarized in the 2018 review

Study settingStarting sampleCurrent BPDInterpretation limit
All included settings10,086 adults with current SUD or in addiction treatment22.1%Combined research samples, not a local population estimate
Inpatient or residential only3,267 adults with current SUD or in addiction treatment26.7%Describes participants recruited in these settings
Outpatient only2,478 adults in the relevant SUD samples15.8%Not a forecast for an individual outpatient program

The setting differences do not show that entering one setting causes or prevents BPD. They describe different sampled groups. Nor should the outpatient percentage be presented as the expected rate at a particular facility. The review did not study River City Recovery, and its combined figures cannot establish the characteristics of a current local program.

The direction of the question matters too. Asking how many people with SUD also have BPD is different from asking how many people with BPD also have SUD. The starting groups differ, so their percentages are not interchangeable.

Why do current, lifetime, and community estimates differ?

Different estimates often answer different questions rather than contradicting one another. A useful individualized planning discussion considers present concerns alongside relevant history. When discussing outpatient options with admissions, describing both is more informative than treating a published lifetime percentage as a statement about someone’s current condition.

In the same mixed-country review of adult clinical, community, forensic, and combined samples published during 2000–2017, 45.46% of participants in the relevant BPD samples had a current unspecified SUD, compared with 75.28% in samples reporting lifetime SUD. Those categories excluded studies reporting alcohol use disorder specifically. The current and lifetime figures came from different sets of studies, not a single group followed from one percentage to the other.

A lifetime diagnosis includes an earlier period when diagnostic requirements were met. It does not necessarily describe an active disorder now. Current estimates address a more recent diagnostic period, with the exact definition depending on the diagnostic system and study methods. Combining those timeframes would obscure what was measured.

  • Identify the starting group. Adults recruited because they have BPD are not the same denominator as adults recruited because they have SUD.
  • Check the timeframe. Current and lifetime diagnoses answer different questions about when a disorder was present.
  • Check the setting and country. Treatment samples and community samples have different recruitment boundaries; neither automatically represents Georgia.
  • Check what was counted. Any SUD, alcohol use disorder, and a particular drug use disorder are not interchangeable categories.

Community recruitment also does not automatically mean a sample represents every adult in a country. The review included both broader population research and selected community groups. The recruitment description matters as much as the label “community.” A finding from a selected group should retain that boundary when discussed.

Multiple substance diagnoses create another counting issue. One participant may have more than one SUD. The review therefore avoided adding certain substance-specific findings together, because doing so could count the same person more than once.

Why do shared symptoms establish neither diagnosis nor cause?

Impulsivity and emotional instability can be relevant to both conditions, but shared features do not settle a diagnosis. They are reasons to describe the full history during person-centered treatment planning, not reasons to select a label independently. An admissions conversation can explain assessment processes without turning a symptom description into a confirmed condition.

The review’s discussion of symptom overlap identifies an important measurement problem: substance-related behavior can contribute to the impulsivity feature considered in BPD assessment. However, studies examining co-occurrence independently of shared features still found substantial overlap. This means overlapping symptoms alone did not explain the overall research relationship. It does not mean every person with impulsivity has both disorders.

Timing adds another complication. The review notes that intoxication and withdrawal can involve features resembling BPD criteria, including emotional instability and interpersonal problems. Assessors therefore need to establish whether relevant experiences also occur outside those phases. This is a professional assessment issue, not a reason to delay seeking help or attempt to resolve diagnostic uncertainty through self-directed substance changes.

NIMH adds a separate distinction: impulsive behaviors occurring mostly during elevated mood or energy may reflect another disorder, such as a mood disorder, rather than BPD. The surrounding pattern matters. A single behavior, a difficult argument, or a period of reckless decision-making cannot resolve these differences.

Co-occurrence also does not establish causation. Many studies in the review were cross-sectional, meaning they examined people at one point rather than establishing the sequence over time. Such designs cannot determine which condition came first or whether either caused the other. The authors discuss possible shared influences, including emotional regulation, impulsivity, and early environmental factors, while stating that their review cannot definitively answer whether SUD is a cause or consequence of BPD.

Risk factors are not individual explanations. NIMH notes that experiencing a risk factor does not mean someone will develop BPD, and people without identified risk factors can have it. Research about shared vulnerability should not become a judgment about someone’s family, character, or future.

What can the evidence support about care and treatment?

The evidence supports taking both substance-related and mental health concerns seriously, not choosing a treatment from a co-occurrence percentage. Individualized addiction treatment planning considers how identified needs fit together. River City Recovery’s admissions team can explain general outpatient options, but a contact conversation does not establish BPD-specific service availability or guarantee enrollment.

NIMH describes psychotherapy as the primary treatment for BPD and identifies dialectical behavior therapy, or DBT, as an approach developed specifically for the condition. Its description includes mindfulness and skills related to intense emotions, self-destructive behavior, and relationships. These are condition-specific educational statements. They do not, by themselves, establish a particular effect on alcohol or drug outcomes in people with both BPD and SUD.

The distinction between symptom evidence and substance-related outcome evidence is important. The 2018 review reported that few randomized controlled trials had directly assessed treatment effects on SUD-related problems in people with BPD. That limitation belongs to the evidence available for that review, which covered studies through 2017. It should not be presented as a complete account of every trial conducted afterward, or as proof that a therapy cannot help.

The review also cautions that diagnostic methods affect estimates. Included studies used categorical diagnoses and differing diagnostic systems, and the authors did not rank study estimates by methodological rigor. How researchers defined impairment and applied criteria could change both prevalence and co-occurrence. A large combined sample does not remove those differences.

For a routine conversation with a qualified professional, useful information includes what concerns you, when those experiences occur, their effect on daily functioning, and the substance-use history you want understood. Loved ones can offer support and encourage appropriate evaluation without assigning a diagnosis. NIMH also recognizes that caregivers may benefit from their own counseling and support.

River City Recovery serves adults through outpatient care based in Columbus, GA. Call 706-617-4970 to ask admissions about available options and how assessment informs program consideration. Ask directly about any condition-specific needs rather than assuming a general addiction or mental health service provides specialty BPD treatment. When using the contact form, avoid including sensitive health details.

Frequently asked questions

How often do borderline personality disorder and SUD occur together?

Often, but there is no single rate for every population. A 2018 review of 70 studies published during 2000–2017 found frequent co-occurrence across mixed-country adult samples. Estimates varied by setting, starting diagnosis, and current versus lifetime measurement. These research findings are not a Georgia prevalence estimate or a way to diagnose an individual.

Can impulsivity alone show that someone has BPD?

No. Impulsivity is one possible feature, not a diagnosis by itself. NIMH describes professional diagnosis as involving a thorough discussion of symptoms and personal and family history. The timing and broader pattern matter, especially when substance-related states or elevated mood could complicate interpretation. One behavior cannot establish BPD.

Does the research prove one condition causes the other?

No. The 2018 review explicitly states that it cannot definitively determine whether SUD is a cause or consequence of BPD. Many included studies were cross-sectional and could not establish causal direction. Shared influences and possible interactions are research explanations to investigate, not proven accounts of why one person developed either condition.

Does DBT evidence prove a specific SUD outcome?

Not automatically. NIMH describes DBT as a BPD treatment teaching mindfulness and skills related to emotions, self-destructive behavior, and relationships. A specific substance-related outcome requires evidence measuring that outcome in the relevant population. The 2018 review noted few direct randomized trials at that time; this is not a complete assessment of later research.

Explore related information from River City Recovery

Contact River City Recovery